KARPROLIS

Welcome to the Brand page for “KARPROLIS”, which is offered here for Pharmaceutical research and development; medical and scientific research, conducting clinical trials; medical and scientific research in the fields of treatment for cancer and oncology, and in the fields of treatment of inflammation and autoimmune diseases;.

Its status is currently believed to be active. Its class is unavailable. “KARPROLIS” is believed to be currently owned by “Onyx Pharmaceuticals, Inc.”